Q1 2022

Source filing unavailable

Q1 2022 · —

Revenue—

Net Income

-$97.03M

N/M vs Q1 2021

EPS Diluted

-$2.46

no prior Q1 2021 on file

Operating Income-$89,773,000—

Operating Cash Flow-$58,836,000—

Free Cash Flowderived-$59,082,000—

Same quarter

Metric	Q1 2022	Q1 2021
Net Income	-$97.03M	-$62.12M
EPS Diluted	-$2.46	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biohaven Ltd. · CIK 1935979 · Engraved from SEC EDGAR